Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
2.920
-0.080 (-2.67%)
Jul 18, 2025, 4:00 PM - Market closed

Company Description

Sera Prognostics, Inc., a women’s health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States.

The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother’s risk of delivering spontaneously.

It is also developing a pipeline of novel blood-based biomarker tests for major pregnancy-related conditions, including time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction.

The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Sera Prognostics, Inc.
Sera Prognostics logo
CountryUnited States
Founded2008
IPO DateJul 15, 2021
IndustryMedical Devices
SectorHealthcare
Employees64
CEOEvguenia Lindgardt

Contact Details

Address:
2749 East Parleys Way, Suite 200
Salt Lake City, Utah 84109
United States
Phone801 990 0520
Websitesera.com

Stock Details

Ticker SymbolSERA
ExchangeNASDAQ
Stock TypeCommon Stock
Share ClassClass A Shares
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$16.00
CIK Code0001534969
CUSIP Number81749D107
ISIN NumberUS81749D1072
Employer ID26-1911522
SIC Code8071

Key Executives

NamePosition
Evguenia Lindgardt M.B.A.President, Chief Executive Officer and Director
Dr. John J. Boniface Ph.D.Chief Scientific Officer
Dr. Gregory C. Critchfield M.D., M.S.Executive Director
Dr. Paul Kearney Ph.D.Chief Data Officer
Austin AertsChief Financial Officer
Robert G. HarrisonChief Information Officer
Benjamin G. Jackson J.D.General Counsel
Lee AndersonChief Commercial Officer

Latest SEC Filings

DateTypeTitle
Jul 8, 2025144Filing
Jun 11, 2025144Filing
Jun 11, 2025144Filing
Jun 11, 2025144Filing
Jun 11, 2025144Filing
Jun 11, 2025144Filing
Jun 11, 2025144Filing
Jun 11, 2025144Filing
Jun 11, 2025144Filing
Jun 6, 2025144Filing